Quality of Life in Patients with High-grade Non–muscle-invasive Bladder Cancer Undergoing Standard Versus Reduced Frequency of Bacillus Calmette-Guérin Instillations: The EAU-RF NIMBUS Trial

Autor: Christine G.J.I. van Straten, Christien Caris, Marc-Oliver Grimm, Marc Colombel, Tim Muilwijk, Luis Martínez-Piñeiro, Marko M. Babjuk, Levent N. Türkeri, Joan Palou, Anup Patel, Anders S. Bjartell, Wim P.J. Witjes, Antoine G. van der Heijden, Lambertus A.L.M. Kiemeney

Publikováno v: European Urology Open Science, Vol 56, Iss , Pp 15-24 (2023)

Background: Adverse events induced by intravesical bacillus Calmette-Guérin (BCG) to treat high-grade non–muscle-invasive bladder cancer (NMIBC) often lead to treatment discontinuation. The EAU-RF NIMBUS trial found a reduced number of standard-do

Externí odkaz: https://doaj.org/article/da507eeb842949a392f422cfef50f3e2

Treatment of High-grade Non-muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial 'NIMBUS'

Autor: Marc-Oliver Grimm, Antoine G. van der Heijden, Marc Colombel, Tim Muilwijk, Luis Martínez-Piñeiro, Marko M. Babjuk, Levent N. Türkeri, Joan Palou, Anup Patel, Anders S. Bjartell, Christien Caris, Raymond G. Schipper, Wim P.J. Witjes, Jörg Horstmann, Stefan Machtens, Eberhard Mumperow, Andreas Al Ghazal, Thomas Pulte, Michael Stephan-Odenthal, Georgios Gakis, Mario Kramer, Dirk Zaak, Bernd Schmitz-Dräger, Holger Schreier, Jan Lehmann, Torsten Werner, Jörg Klier, Jan Marin, Wolfgang Rulf, Eva Hellmis, Andreas Schneider, null Spiegelhalder, Manfred Wirth, Theodor Klotz, Henrik Suttmann, Michael Siebels, Gerd Rodemer, Robert Rudolph, Roger Zillmann, M. de Bruin, S. Bos, R. van Moorselaar, T de Reijke, J. Boormans, B. Wijsman, H.H.E. van Melick, E. van Boven, R.P. Meijer, A.G. van der Heijden, H. Vergunst, E. te Slaa, A.M. Leliveld-Kors, Alain Ruffion, Christian Pfister, Morgan Roupret, Jacques Irani, Gabriel Stoica, Siska Van Bruwaene, Filip Ameye, Harm Arentsen, Steven Joniau, Pastora Beardo

Publikováno v: European Urology, 78(5), 690-698. Elsevier
European Urology, 78, 5, pp. 690-698
Grimm, M O, van der Heijden, A G, Colombel, M, Muilwijk, T, Martínez-Piñeiro, L, Babjuk, M M, Türkeri, L N, Palou, J, Patel, A, Bjartell, A S, Caris, C, Schipper, R G, Witjes, W P J & for the EAU Research Foundation NIMBUS Study Group 2020, ' Treatment of High-grade Non–muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations : Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial “NIMBUS” ', European Urology, vol. 78, no. 5, pp. 690-698 . https://doi.org/10.1016/j.eururo.2020.04.066
European urology, 78(5), 690-698. Elsevier
European Urology, 78, 690-698

Background: Intravesical instillation of bacillus Calmette-Guerin (BCG) is an accepted strategy to prevent recurrence of non–muscle-invasive bladder cancer (NMIBC) but associated with significant toxicity. Objective: NIMBUS assessed whether a reduc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80a8b268c7f24e85cc288c439fb7b804
https://doi.org/10.1016/j.eururo.2020.04.066